FORM 10-K

Company

Compass Therapeutics, Inc.

Filed

February 27, 2025

Period of Report

December 31, 2024

Accession Number

0001171843-25-001106

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →